{"entity":{"id":"idea-fund-translational-fellowships","kind":"idea","name":"Two-year translational fellowships that pay scientists to develop their own discovery","aka":[],"tldr":"Postdocs who make a translatable discovery usually leave it behind when their contract ends. A two-year fellowship with salary, a project budget of $250,000 to $500,000 and mentors from drug development, regulation and the clinic would pay them to turn it into a candidate drug, diagnostic or device, with the option to license it or found a company.","summary":"Fellowships with salary, a project budget of $250,000 to $500,000 and structured mentoring from drug developers, regulatory experts and clinicians, awarded to postdoctoral scientists or clinical fellows to translate a specific finding: target validation, lead optimisation, assay development, prototype device. Fellows are hosted in translational institutes or academic drug discovery units and have the option to found a company or license the asset. Precedents include the Wellcome and MRC translational fellowships, Blavatnik Fellowships and the EMBL-EBI industry programme; oncology lacks a dedicated scheme at scale.","asOf":"2026-09-08","links":[{"label":"Bottleneck evidence (The valley of death between lab and product): Butler, Translational research: crossing the valley of death (Nature 2008)","url":"https://doi.org/10.1038/453840a"}],"tags":[],"related":["idea-fund-translational-institutes-gmp","idea-fund-surgeon-scientist-pathway","idea-fund-protected-time-physician-scientists"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-translational-valley","b-workforce"],"keyPapers":["paper-butler-nature"],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Translational fellows advance their assets to a defined milestone (validated target, lead series, IND-enabling start, prototype in patients) in at least half of cases, and a third of assets attract follow-on funding or licensing within two years of the fellowship, versus a small minority of comparable unfunded discoveries.","rationale":"Discoveries are stranded because the people who understand them are on short contracts with incentives to publish and move; paying the discoverer to translate is cheaper than paying a company to rediscover. Existing translational fellowship schemes report high rates of spin-out and licensing.","test":"Run fifty fellowships over three years and pre-register the milestone and follow-on metrics against a matched cohort of discoveries from the same institutions without fellowship support.","maturity":"speculative","actor":"research","cost":"medium","horizonYears":4},"route":"/ideas/idea-fund-translational-fellowships/","neighbours":{"idea":[{"id":"idea-fund-surgeon-scientist-pathway","kind":"idea","name":"Funded research pathways for surgeon-scientists and radiation oncologist-scientists","route":"/ideas/idea-fund-surgeon-scientist-pathway/"},{"id":"idea-fund-protected-time-physician-scientists","kind":"idea","name":"Hospital-funded protected time for clinician-scientists, repaid by trial revenue","route":"/ideas/idea-fund-protected-time-physician-scientists/"},{"id":"idea-fund-translational-institutes-gmp","kind":"idea","name":"Regional translational institutes with academic GMP suites and IND teams","route":"/ideas/idea-fund-translational-institutes-gmp/"}],"bottleneck":[{"id":"b-workforce","kind":"bottleneck","name":"Not enough oncologists, nurses, pathologists, physicists","route":"/bottlenecks/b-workforce/"},{"id":"b-translational-valley","kind":"bottleneck","name":"The valley of death between lab and product","route":"/bottlenecks/b-translational-valley/"}],"paper":[{"id":"paper-butler-nature","kind":"paper","name":"Translational research: crossing the valley of death","route":"/key-papers/paper-butler-nature/"}]}}